N 6 -methyladenosine regulates glycolysis of cancer cells through PDK4
Studies on biological functions of N -methyladenosine (m A) modification in mRNA have sprung up in recent years. We find m A can positively regulate the glycolysis of cancer cells. Specifically, m A-sequencing and functional studies confirm that pyruvate dehydrogenase kinase 4 (PDK4) is involved in...
Saved in:
Published in | Nature communications Vol. 11; no. 1; pp. 2578 - 16 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Nature Portfolio
22.05.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Studies on biological functions of N
-methyladenosine (m
A) modification in mRNA have sprung up in recent years. We find m
A can positively regulate the glycolysis of cancer cells. Specifically, m
A-sequencing and functional studies confirm that pyruvate dehydrogenase kinase 4 (PDK4) is involved in m
A regulated glycolysis and ATP generation. The m
A modified 5'UTR of PDK4 positively regulates its translation elongation and mRNA stability via binding with YTHDF1/eEF-2 complex and IGF2BP3, respectively. Targeted specific demethylation of PDK4 m
A by dm
ACRISPR system can significantly decrease the expression of PDK4 and glycolysis of cancer cells. Further, TATA-binding protein (TBP) can transcriptionally increase the expression of Mettl3 in cervical cancer cells via binding to its promoter. In vivo and clinical data confirm the positive roles of m
A/PDK4 in tumor growth and progression of cervical and liver cancer. Our study reveals that m
A regulates glycolysis of cancer cells through PDK4. |
---|---|
ISSN: | 2041-1723 |
DOI: | 10.1038/s41467-020-16306-5 |